U.S. market Closed. Opens in 1 day 9 hours 10 minutes

ABVC | ABVC BioPharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-09-302015-09-302014-09-302013-09-302012-09-302011-12-152010-09-302009-09-302008-09-302007-09-302006-12-312005-12-312004-12-312003-12-312002-12-31
Revenue152.43K969.78K355.80K483.05K701.72K6.96K3.20K32.003.36KN/A7.79K5.71K3.19K14.86K-271.72K25.09K41.67KN/AN/A57.49K13.67K10.00K
Cost of Revenue302.04K286.42K5.09K18.72K20.14K185.28K2.25K32.00521.00N/AN/AN/AN/AN/A271.72KN/AN/AN/AN/A32.39K25.76K10.00K
Gross Profit-149.61K683.37K350.71K464.33K681.58K-178.32K947.00N/A2.84KN/A7.79K5.71K3.19K14.86K-543.44K25.09K41.67KN/AN/A25.10K-12.09KN/A
Operating Expenses8.07M15.80M11.70M8.97M4.14M1.39M1.99M4.50M35.12K70.00185.05K1.15M1.89M1.70M4.91M5.38M4.46M26.82K17.57K23.10K11.72K20.00K
Selling, General & Admin7.00M13.10M11.05M8.42M3.09M723.95K1.74M4.50M35.12KN/AN/AN/A1.89M1.90M4.91M5.38M4.46M26.82K17.57K23.10K11.72K20.00K
Research & Development1.06M2.69M1.00M549.66K1.05M669.67K256.68K10.00MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/A83.00K-360.90K199.64K116.85KN/A63.39KN/A35.12K70.00185.05K1.15MN/A-206.98KN/AN/AN/AN/AN/AN/AN/A0
Operating Income-8.22M-15.11M-11.35M-8.51M-3.46M-1.39M-1.99M-4.50M-32.28K-70.00-177.26K-1.14M-1.89M-1.68M-4.91M-5.35M-4.42M-26.82K-17.57K2.01K-23.80K-20.00K
Other Expenses / Income-2.44M-400.18K495.14K-2.31M-551.50K-1.31M-3.03M-9.67KN/AN/A-49.09K141.10K669.21K-11.59K-271.72K-1.42M-235.57K-636.83K-294.47K532.00-1.56KN/A
Before Tax Income-10.65M-15.51M-11.21M-10.81M-4.01M-4.10M-7.03M-4.51M-32.28K-70.00-226.35K-1.00M-1.01MN/A-5.18M-6.77MN/A-25.40K-16.36K2.54K-25.36K-20.00K
Income Tax Expenses256.01K797.78K825.02K-220.35K-77.04K1.85K-360.39K836.00-1.89MN/A49.09K67.64K-1.75M218.57K-142.00-5.78K-20.94K-1.43K9.10K-532.00N/AN/A
Net Income-10.52M-16.31M-12.04M-10.59M-3.93M-4.10M-5.05M-4.51M-32.28K-70.00-226.35K-1.07M-1.22M-1.90M-5.18M-6.77M-4.65M-25.40K-26.67K2.54K-25.36K-20.00K
Interest Expenses2.49M293.97K227.21K405.03K482.01K155.93K222.06K10.17KN/AN/A49.09K87.70K204.92K218.57K271.86K1.42M256.51K-1.43K-1.21KN/A1.56KN/A
Basic Shares Outstanding4.34M3.17M2.51M1.97M1.75M1.16M170.67K1.08M87.27K190.00190.00190.0049.0022.0022.002.03K3.67K3.67K3.67K3.67K22.0028.61M
Diluted Shares Outstanding4.34M3.17M2.51M1.97M1.75M1.19M170.67K1.08M87.27K190.00190.00190.0049.0022.0022.002.03K3.67K3.67K3.67K3.67K22.0028.61M
EBITDA-8.13M-15.20M-10.97M-10.37M-3.47M-2.74M-4.00M561.00-32.28K-70.00-153.40K-881.20K-979.55K-1.64M-4.87M-5.31M-4.40M-26.82K-17.57K-14.60K-23.80K-20.00K
EBITDA Margin-5,335.18%-1,567.03%-3,083.68%-2,147.16%-494.95%-39,404.15%-125,041.99%1,753.13%-960.74%0.00%-1,969.95%-15,421.68%-30,706.99%-11,017.80%1,790.55%-21,167.87%-10,565.76%0.00%0.00%-25.39%-174.13%-200.00%
EBIT-7.77M-15.22M-10.98M-10.41M-3.53M-3.94M-5.19M-4.50M-1.93M-70.00-128.17K-914.24K-2.76M-1.46M-4.91M-5.35M-4.42M-28.25K-18.79K2.01K-23.80K-20.00K
EBIT Margin-5,095.00%-1,569.49%-3,087.05%-2,154.85%-502.80%-56,692.40%-162,284.29%-14,052,478.13%-57,318.30%0.00%-1,645.90%-16,000.07%-86,582.82%-9,851.41%1,807.19%-21,340.32%-10,596.38%0.00%0.00%3.49%-174.13%-200.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-09-302015-09-302014-09-302013-09-302012-09-302011-12-152010-09-302009-09-302008-09-302007-09-302006-12-312005-12-312004-12-312003-12-312002-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙